Dr. Shevkoplyas is a Professor of Biomedical Engineering at the University of Houston. He received a BS and MS in Applied Mathematics & Physics from Moscow Institute of Physics & Technology (Russia) in 2000, and a PhD in Biomedical Engineering from Boston University in 2005. After completing a postdoctoral fellowship in Chemistry and Chemical Biology at Harvard University (2005-2008), he served on the faculty of Tulane University as an Assistant and Associate Professor of Biomedical Engineering (2008-2013).
His current research is focused on the development, clinical translation and commercialization of microfluidic devices and systems for high-throughput cells separation in the fields of transfusion medicine and cellular therapy.
His research has been funded by the National Blood Foundation, the Bill & Melinda Gates Foundation, U.S. Department of Defense, Cancer Prevention and Research Institute of Texas, National Science Foundation, National Institutes of Health, and industrial partners.
The primary focus of the Blood Microfluidics Laboratory is the development and clinical translation of high-throughput microfluidic devices and single-cell analysis tools in the field of blood storage and transfusion medicine. We are currently developing novel technologies for improving the safety and efficacy of blood transfusions, and making blood products available for life-saving transfusions in resource-limited settings. An additional significant thrust of our research program is the development of enabling technology for low-cost, point-of-care diagnostics in resource-limited settings.